Connect Sign In
ARUP medical directors and scientists presented key molecular pathology advancements at AMP 2024 on topics such as viral load prediction, automated DNA extraction, and parasite detection.
This edition features interviews with company leaders describing ARUP’s approaches to comply with the FDA’s rule and a video about how ARUP helped a family on a rare disease diagnostic journey.
FDA leaders answered questions on artificial intelligence (AI), international regulations, and representation in clinical trials during the Utah Life Sciences Summit.
Ryan Nelson, PharmD, received a Double Helix Award for his work on MetaCensus during the Standardizing Laboratory Practices in Pharmacogenomics (STRIPE) Annual Meeting and Consensus Workshop.
Laboratory tests, including those for fluid biomarkers, may be used to diagnose Alzheimer's disease. ARUP Consult details using such tests to help clinicians order the right test at the right time.
The University of Utah Licensing and Technology Office awards recognize impactful research and innovation. Though retired, Wittwer is active in advancing molecular diagnostics and mentoring others.
ARUP Laboratories is partnering with Augurex Life Sciences Corp. to include the 14-3-3η test in the ARUP test menu to enhance the early detection of rheumatoid arthritis.
Donna Mills has regularly donated whole blood and platelets with ARUP since she was 16. Now, she’s won two tickets to Taylor Swift’s Eras Tour from ARUP Blood Services’ raffle.
ARUP wins award for providing employees bike-friendly amenities, including a secure bike storage facility and charging stations for ebikes, as well as showers and changing rooms for use after a ride.
Updated ARUP Consult® resources on hematologic malignancies describe how laboratory tests can be used in the diagnosis, prognosis, treatment, and management of these diseases.
A new ARUP Consult® topic on testing for preeclampsia, which can be difficult to diagnose, distills guidelines from several sources to help clinicians order the right test at the right time.
ARUP has been awarded a CDC contract for avian influenza A (H5N1) test development, which recognizes our expertise and experience with assay development and our desire to serve public health needs.
